Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomised Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated With Trastuzumab (Herceptin®) for Metastatic Breast Cancer

NCT00639366 is registered in ClinicalTrials.gov with Anglo Celtic Cooperative Oncology Group as lead sponsor.

NCT NCT00639366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomised Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated With Trastuzumab (Herceptin®) for Metastatic Breast Cancer
Lead sponsor
Anglo Celtic Cooperative Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
October 31, 2010
Enrollment
390 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer